Matches in Wikidata for { <http://www.wikidata.org/entity/Q98208052> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q98208052 description "article scientifique publié en 2020" @default.
- Q98208052 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98208052 description "bài báo khoa học" @default.
- Q98208052 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98208052 description "scientific article published on 04 August 2020" @default.
- Q98208052 description "wetenschappelijk artikel" @default.
- Q98208052 description "наукова стаття, опублікована 4 серпня 2020" @default.
- Q98208052 name "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 name "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 type Item @default.
- Q98208052 label "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 label "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 prefLabel "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 prefLabel "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 P1433 Q98208052-1C0FE193-ACED-4205-9D97-169AB5B445A6 @default.
- Q98208052 P1476 Q98208052-AEEF10DE-C8B6-48FD-96C3-5E2FE3FBA857 @default.
- Q98208052 P2093 Q98208052-0DE41916-B7B7-4350-BF8B-CDB0C144500B @default.
- Q98208052 P2093 Q98208052-17388F6C-817F-40E5-A760-558BA152C5C7 @default.
- Q98208052 P2093 Q98208052-19A645C8-B208-4ABA-8077-A71550F5DDA7 @default.
- Q98208052 P2093 Q98208052-1BB6642F-EFA9-4001-97E4-F97C286DA766 @default.
- Q98208052 P2093 Q98208052-2177089B-77B6-4437-BC1C-8CE2738957D2 @default.
- Q98208052 P2093 Q98208052-25505347-C904-4FEC-8659-1E577BEA133F @default.
- Q98208052 P2093 Q98208052-34976ADD-2BD2-4B4E-992A-5D33E7D1C796 @default.
- Q98208052 P2093 Q98208052-3B4972DF-50C2-4E09-91CC-34218E520C96 @default.
- Q98208052 P2093 Q98208052-3EE60154-EDBF-464C-B900-16B7C9199D35 @default.
- Q98208052 P2093 Q98208052-441EC5B7-022E-413F-8A2E-C61CE823040B @default.
- Q98208052 P2093 Q98208052-486A0F85-EFDA-4B82-8CCF-05CB9EEFE6A8 @default.
- Q98208052 P2093 Q98208052-4C8E1694-D1E4-4E2C-8777-A10E2103180F @default.
- Q98208052 P2093 Q98208052-5DF20790-2414-400F-8D82-66970BCD2193 @default.
- Q98208052 P2093 Q98208052-70136518-A9A4-4D13-9D40-04DFC126D876 @default.
- Q98208052 P2093 Q98208052-86E2EDF1-580C-4B03-A3BD-61E2A5C1A2D8 @default.
- Q98208052 P2093 Q98208052-97DE1C5E-9302-4147-8D4D-B43D9D33DF47 @default.
- Q98208052 P2093 Q98208052-A1F84878-6AAF-4B83-BA4C-2B0C46703931 @default.
- Q98208052 P2093 Q98208052-C776353B-A22B-4E1F-A100-90EF2574A10C @default.
- Q98208052 P2093 Q98208052-CF6AACD7-6109-41C3-8D0C-64D6DC9C01CC @default.
- Q98208052 P2093 Q98208052-CFAEF68F-9543-4FC3-B7E7-F65B778263A2 @default.
- Q98208052 P2093 Q98208052-DDB2EC9E-5187-44CD-B02C-C38D393D6BAE @default.
- Q98208052 P2093 Q98208052-ECAB5C27-893E-44D4-A7B8-88860C209441 @default.
- Q98208052 P31 Q98208052-68A94877-29F5-476D-8777-CE3B250F8D39 @default.
- Q98208052 P356 Q98208052-F1C869B4-67D8-4415-BE59-915F8F59EED4 @default.
- Q98208052 P577 Q98208052-7B22453B-4A1A-4A6E-AA72-EDC13F36F31F @default.
- Q98208052 P698 Q98208052-8704CEC1-878B-495F-BC37-0A40A43C318A @default.
- Q98208052 P932 Q98208052-B1ED7E41-043F-479A-A384-941475778C06 @default.
- Q98208052 P356 TJH.GALENOS.2020.2020.0070 @default.
- Q98208052 P698 32755128 @default.
- Q98208052 P1433 Q26842860 @default.
- Q98208052 P1476 "Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients" @default.
- Q98208052 P2093 "Aslihan Sezgin" @default.
- Q98208052 P2093 "Bulut Yurtsever" @default.
- Q98208052 P2093 "Cansu Hemsinlioglu" @default.
- Q98208052 P2093 "Cavit Kerem Kayhan" @default.
- Q98208052 P2093 "Cihan Taştan" @default.
- Q98208052 P2093 "Derya Dilek Kancagi" @default.
- Q98208052 P2093 "Didem Cakirsoy" @default.
- Q98208052 P2093 "Ebru Kizilkilic" @default.
- Q98208052 P2093 "Ercument Ovali" @default.
- Q98208052 P2093 "Fatma Tokat" @default.
- Q98208052 P2093 "Koray Yalcin" @default.
- Q98208052 P2093 "Merve Acikel Elmas" @default.
- Q98208052 P2093 "Muhammet Yilanci" @default.
- Q98208052 P2093 "Raife Dilek Turan" @default.
- Q98208052 P2093 "Samed Ozer" @default.
- Q98208052 P2093 "Selcuk Birdogan" @default.
- Q98208052 P2093 "Selen Abanuz" @default.
- Q98208052 P2093 "Selin Mert" @default.
- Q98208052 P2093 "Serap Arbak" @default.
- Q98208052 P2093 "Siret Ratip" @default.
- Q98208052 P2093 "Umit Ince" @default.
- Q98208052 P2093 "Utku Seyis" @default.
- Q98208052 P31 Q13442814 @default.
- Q98208052 P356 "10.4274/TJH.GALENOS.2020.2020.0070" @default.
- Q98208052 P577 "2020-08-04T00:00:00Z" @default.
- Q98208052 P698 "32755128" @default.
- Q98208052 P932 "7702660" @default.